Other functions - preclinical pharmacology and toxicology studies - contract orientation meeting with NCI, office of acquisitions
Ended Awarded Last action
- Contract number
- HHSN26100001
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,182
Award facts
- Opportunity
-
- N01CN2500026 Solicitation number
- Preclinical Pharmacology and Toxicology Studies Award Notice · Posted Aug 25, 2011
- Contract value 100% obligated
- $3,181.51 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$356 | |
| Other Administrative Action | $0 | |
| Original award | $3,538 |
Quick answers
Who was awarded contract HHSN26100001?
HHSN26100001 was awarded to Sri International by National Cancer Institute (National Institutes of Health) on September 20, 2012.
How much is contract HHSN26100001 worth?
The government has obligated $3,182 on HHSN26100001.
Is contract HHSN26100001 an order under another contract?
Yes. HHSN26100001 is a delivery order under HHSN261201200026I, an indefinite delivery contract, on Preclinical Pharmacology and Toxicology Studies 2012-2014.
Was contract HHSN26100001 competed?
The extent of competition for HHSN26100001 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award